Plain-English translation of NCT07272772 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new type of imaging scan called 18F-FAPI-74 PET/CT to help doctors find colon cancer more accurately. Unlike standard imaging, this new scan targets proteins that are often found in cancer tissue, which may help doctors detect cancer spread to lymph nodes or other areas of the body more reliably.
Current imaging methods used for colon cancer have limitations and sometimes miss cancer that has spread. Researchers believe this new imaging approach could be more effective at finding cancer in its early stages or when it returns, which could help guide better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would undergo a PET-CT imaging scan using the new 18F-FAPI-74 tracer. The scan involves receiving an injection of the tracer, waiting a short time for it to reach the cancer cells, and then lying still in a scanner for imaging. The study collects data between 2024 and 2026, and you may be scanned during initial cancer staging or during follow-up if recurrence is suspected.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Finland